Tagged with FEI

China Bridge Consulting’s Zoe Leung examines the journeys of Chinese-developed COVID-19 vaccines outside of China’s borders, drawing on a number of examples, from Sinopharm’s work on boosting vaccine supply in the UAE to Sinovac’s Egyptian and Chilean partnerships, CanSino’s steady progress in Pakistan and Mexico, and Zhifei Longcom’s Uzbek success.*  …

China China’s new Amended Drug Administration Law is being enacted to strengthen and streamline its regulation of the pharmaceutical industry as well as address prominent problems such as counterfeit drugs, substandard drugs and high drug prices. Fangda Partners’ Josh Shin explains how the new law strengthens penalties for counterfeit and substandard…

Egypt Dr Osama Rostom, deputy head of the Pharmaceutical Chamber of the Federation of Egyptian Industries (FEI), explains how the Egyptian healthcare ecosystem has improved during the last three years thanks to an intensive collaboration between the private and public side. He also provides solutions for accelerating pharma exports from Egypt…

Bulgaria Illiana Paunova is the first Executive Director and one of the founders of the Bulgarian Medicines Verification Organization (BgMVO), an organization which has been set up to fight against the counterfeit medicines in the country. She explains the BgMVO’s role as well as objectives within the pharmaceutical industry as the…

Switzerland “Robust solutions, the capability to implement them and the ability to do so globally” – The executive president of product and brand protection solutions at SICPA explains why the company is the right partner for companies in the pharmaceutical, healthcare and life science industry to fight counterfeiters. You joined SICPA…